Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Hypromellose may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Hypromellose
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

FOR Artelac contains the active ingredient hypromellose which acts as a lubricant to treat symptoms of dry eye. It is a soothing solution that is used as an artificial tear when the eyes are lacking in tears. Your eyes will normally produce just enough natural tears to allow them to move easily and comfortably. If your eyes do not produce enough tears they can become dry, red and painful. Your drops keep the surface of the eye lubricated (moist) when production of tears is less than normal, and has a refreshing, cooling action. The hypromellose in these drops increases the thickness of the solution which has a moisturising effect and helps the solution to stay in contact with your eye for a longer period of time. Artelac can be used by children, adults and the elderly.

What you need to know before you take it

E ARTELAC Do NOT use Artelac

  • If you are allergic to hypromellose or any of the ingredients of this medicine (listed in Section 6). Warnings and precautions
  • Talk to your doctor or pharmacist before using Artelac.
  • If you wear soft contact lenses – take out your lenses before using Artelac and then wait for at least 15 minutes after using these drops before putting your lenses back in.
  • If your eyes continue to feel dry and sore, stop using your drops and tell your

doctor. Other medicines and Artelac

  • Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Pregnancy, breast-feeding and fertility
  • If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Driving and using machines
  • All eye drops can cause a short term blurring of vision when first used, so you should wait until your eyes are clear before driving or using machines. Important information about some of the ingredients in this medicine: Artelac contains disodium phosphate dodecahydrate and sodium dihydrogen phosphate dihydrate
  • This medicine contains 0.051 mg phosphates in each drop which is equivalent to 1.84 mg/ml. If you suffer from severe damage to the clear layer at the front of the eye (the cornea), phosphates may cause in very rare cases cloudy patches on the cornea due to calcium build-up during treatment.

How to take it

ARTELAC Always use your solution exactly as your doctor or pharmacist has told you to. Check with your doctor or pharmacist if you are not sure. This medicine is only to be used as drops applied into one or both eye(s). The recommended dose is The usual dose is to apply 1 drop in the corner of the eye, nearest the nose, 3 to 5 times each day or as required to give enough lubrication. Ensure the dropper tip does not touch any surface including the eye surface. Dry eye is a condition that varies from person to person. Use the drops as often as you think necessary. Directions for use

  • Wash your hands before using your drops
  • Sit down in front of a mirror so that you can see what you are doing
  • Wipe your eyes to clear any residual wateriness or discharge
  • Unscrew the cap from the bottle and check the dropper is clean
  • Pull your lower eyelid gently down, and then carefully place one drop inside the lower eyelid, in the corner nearest the nose (see picture)

Take care not to touch the dropper with your eye or fingers

  • Release the lower eyelid, and blink a few times to make sure the eye is covered by the liquid
  • Repeat the procedure for your other eye
  • When you have finished, put the cap back on the bottle Tightly If you use more Artelac than you should lf you accidentally use a larger dose than recommended, this may cause some blurring of vision, which will soon pass. If you have any further questions on the use of this product, ask your doctor or pharmacist. If you forget to take Artelac Do not take a double dose to make up for a forgotten dose. 4. POSSIBLE SIDE EFFECTS Like all medicines, Artelac can cause side effects, although not everybody gets them. In very rare cases, some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment. You may briefly have blurred vision or a slight stinging feeling after using your drops. Frequency cannot be estimated from the available data. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any

Possible side effects

not listed in this leaflet. You can also report side effects directly via: United Kingdom: Yellow Card Scheme – Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store Ireland HPRA Pharmacovigilance Website: http://www.hpra.ie By reporting side effects you can help provide more information on the safety of this medicine.

How to store it

ARTELAC

  • Keep out of the reach and sight of children.
  • Do not use this medicine after its expiry date which is stated on the label.
  • The expiry date refers to the last day of that month.
  • If the expiry date has passed, take the medicine back to your pharmacist.
  • Do not store your drops above 25°C.
  • Your eye drops are sterile until first opened. It is important to keep the drops as clean as possible during use. Do not touch the dropper tip on the eye or any other surface.
  • Your drops come in bottle which should be thrown away 28 days after first opening.
  • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Contents of the pack and other information

What Artelac contains

  • The active ingredient is: hypromellose 3.2 mg/ml (0.32 % w/v).
  • The other ingredients are: cetrimide, disodium phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, disodium edetate, sorbitol and water for injections. The preservative in your eye drops is cetrimide, which means that Artelac can be used if your eyes are sensitive to other preservatives such as benzalkonium chloride. What Artelac looks like and contents of the pack These eye drops are a clear sterile solution and are supplied in plastic eye drop bottles. Each bottle has a volume of 10 ml. Marketing Authorisation Holder MAH (UK): Bausch & Lomb UK Ltd, 106 London Road, Kingston-Upon-Thames, Surrey, KT2 6TN, UK. PL03468/0032 MAH (IE): Bausch + Lomb Ireland Ltd., 3013 Lake Drive, Citywest Business Campus, Dublin 24 Ireland. PA23259/004/001 Manufacturer Dr Gerhard Mann Chem-pharm Fabrik GmbH, 13581 Berlin, Germany This leaflet was approved December 2021

Frequently asked questions about Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution

How do I take Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution?

Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution comes as eye drops containing 10ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution?

The active substance in Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution is hypromellose.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Hypromellose (8 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

This medicinal product acts as a lubricant and artificial tear in the symptomatic treatment of dehydration of the cornea and conjunctiva due to impaired lacrimal secretion and functional disorders as a result of topical or systemic diseases, or caused by deficient or incomplete eyelid closure. Artelac 3.2 mg/ml Eye Drops Solution is indicated in adults and children.

4.2. Posology and method of administration

Posology

Suitable for use in adults and children. Unless otherwise directed, instil 1 drop into the conjunctival sac (corner of the eye, nearest the nose) 3 to 5 times per day or as required, to provide sufficient lubrication. Therapy of dry eye syndrome requires an individual dosage regimen. Method of administration

For ocular use only.

4.3. Contraindications

Hypersensitivity to the active substance (hypromellose) or to any of the excipients. Listed in section 6.1.

4.4. Special warnings and precautions for use

Stop treatment and consult a physician if irritation persists or worsens or new eye signs or symptoms develop. Wearers of soft contact lenses should remove their lenses before Artelac 3.2 mg/ml Eye Drops Solution is administered and should wait for at least 15 minutes before they insert them again. Ensure the dropper tip does not touch any surface including the eye surface.

4.5. Interaction with other medicinal products and other forms of interaction

None.

4.6. Fertility, pregnancy and lactation

Pregnancy

Artelac 3.2 mg/ml Eye Drops Solution can be used during pregnancy. Breast-feeding

Artelac 3.2 mg/ml Eye Drops Solution can be used during and lactation. Fertility

Artelac 3.2 mg/ml Eye Drops Solution is not expected to have any effect on fertility.

4.7. Effects on ability to drive and use machines

Artelac 3.2 mg/ml Eye Drops Solution on instillation may cause a short term blurring of vision when first used. If affected wait until vision has cleared before driving or operating machinery.

4.8. Undesirable effects

The following adverse reactions have been reported following administration of Artelac 3.2 mg/ml Eye Drops Solution. Eye disorder:

Very rare (<1/10,000):Cases of corneal calcification have been reported very rarely in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas.Not known: Brief blurred vision or a slight stinging sensation on instilling Artelac 3.2 mg/ml Eye Drops Solution. Reporting of suspected adverse reactions:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme; Website: www.mhra.gov.uk/yellowcard.

4.9. Overdose

No case of overdose has been reported.

🇵🇱 Known in Poland as

Medicines sold in Poland with the same active substance: W Polsce znany jako

  • ArtelacHypromellosum · eye / ear / nose

Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →

💬 Ask about this leaflet

Ask anything about Artelac 10ml hypromellose 0.32% with preservative, Eye drops solution. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →